Apatinib Plus Camrelizumab With/Without Chemoembolization for Hepatocellular Carcinoma: A Real-World Experience of a Single Center

OBJECTIVE: This study was conducted in order to compare the efficacy and safety of transarterial chemoembolization (TACE) plus apatinib plus camrelizumab (TACE+AC) and apatinib plus camrelizumab (AC) in the treatment of unresectable hepatocellular carcinoma (HCC) in a real-world setting. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Shuguang, Zhou, Chen, Yang, Chongtu, Wang, Chaoyang, Liu, Jiacheng, Wang, Yingliang, Huang, Songjiang, Li, Tongqiang, Chen, Yang, Bai, Yaowei, Yao, Wei, Xiong, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841670/
https://www.ncbi.nlm.nih.gov/pubmed/35174073
http://dx.doi.org/10.3389/fonc.2021.835889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841670/
https://www.ncbi.nlm.nih.gov/pubmed/35174073
http://dx.doi.org/10.3389/fonc.2021.835889

Ejemplares similares